Empagliflozin in the Treatment of Heart Failure with Reduced Ejection Fraction in Addition to Background Therapies and Therapeutic Combinations (Emperor-Reduced): a Post-Hoc Analysis of a Randomised, Double-Blind Trial

AuthID
P-00V-V90
100
Author(s)
Verma S.
·
Dhingra N.K.
·
Butler J.
·
Filippatos G.
·
Sattar N.
·
[+1]·
[+17]·
[+18]·
[+44]·
Glenny J.
·
Alvarez Lorio C.
·
Campos R.
·
Facta A.
·
Fernandez A.
·
Ahuad Guerrero R.
·
Lobo Márquez L.
1
Group Author(s)
EMPEROR-Reduced Trial Comm Investi
Document Type
Article
Year published
2022
Published
in LANCET DIABETES & ENDOCRINOLOGY, ISSN: 2213-8587
Volume: 10, Issue: 1, Pages: 35-45 (11)
Indexing
Publication Identifiers
Scopus: 2-s2.0-85121124575
Wos: WOS:000730675600020
Source Identifiers
ISSN: 2213-8587
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Verma S.;   2 Dhingra N.K.;   3 Butler J.;
4 Anker S.D.;   5 Ferreira J.P. ;   6 Filippatos G.;
7 Januzzi J.L.;   8 Lam C.S.P.;   9 Sattar N.;
10 Peil B.;   11 Nordaby M.;   12 Brueckmann M.;
13 Pocock S.J.;   14 Zannad F.;   15 Packer M.;
16 Packer M.;   17 Anker S.;   18 Butler J.;
19 Filippatos G.;   20 Pocock S.;   21 Zannad F.;
22 Ferreira J.P.;   23 Brueckmann M.;   24 George J.;
25 Jamal W.;   26 Welty F.K.;   27 Palmer M.;
28 Clayton T.;   29 Parhofer K.G.;   30 Pedersen T.R.;
31 Greenberg B.;   32 Konstam M.A.;   33 Lees K.R.;
34 Carson P.;   35 Doehner W.;   36 Miller A.;
37 Haas M.;   38 Pehrson S.;   39 Komajda M.;
40 Anand I.;   41 Teerlink J.;   42 Rabinstein A.;
43 Steiner T.;   44 Kamel H.;   45 Tsivgoulis G.;
46 Lewis J.;   47 Freston J.;   48 Kaplowitz N.;
49 Mann J.;   50 Petrie J.;   51 Perrone S.;
52 Nicholls S.;   53 Janssens S.;   54 Bocchi E.;
55 Giannetti N.;   56 Verma S.;   57 Zhang J.;
58 Spinar J.;   59 Seronde M.F.;   60 Boehm M.;
61 Merkely B.;   62 Chopra V.;   63 Senni M.;
64 Taddi S.;   65 Tsutsui H.;   66 Choi D.J.;
67 Chuquiure E.;   68 La Rocca H.P.B.;   69 Ponikowski P.;
70 Juanatey J.R.G.;   71 Squire I.;   72 Januzzi J.;
73 Pina I.;   74 Bernstein R.;   75 Cheung A.;
76 Green J.;   77 Kaul S.;   78 Lam C.;
79 Lip G.;   80 Marx N.;   81 McCullough P.;
82 Mehta C.;   83 Rosenstock J.;   84 Sattar N.;
85 Scirica B.;   86 Shah S.;   87 Wanner C.;
88 Aizenberg D.;   89 Cartasegna L.;   90 Colombo Berra F.;
91 Colombo H.;   92 Fernandez Moutin M.;   93 Glenny J.;
94 Alvarez Lorio C.;   95 Anauch D.;   96 Campos R.;
97 Facta A.;   98 Fernandez A.;   99 Ahuad Guerrero R.;
100 Lobo Márquez L.;